Mary Erickson

Mary Erickson has extensive experience in the pharmaceutical industry, with a focus on clinical research and medical affairs. Mary started their career as a Senior Investigator at Genset Corporation in 1998. Mary then worked as a Senior Scientist at Valigen, Inc. from 2001 to 2002. Mary joined Amylin Pharmaceuticals in 2002 and held positions as Principal Investigator Discovery Biology and later as Director, Medical Affairs until 2013. Mary then joined Bristol Myers Squibb as the Therapeutic Area Lead, Metabolics, US Medical Operations from 2013 to 2015. Currently, Mary is working at Intercept Pharmaceuticals as the Vice President, Clinical Research, Translational Medicine since 2021. Prior to this, they served as the Executive Director, Clinical Research, Non-Clinical from 2018 to 2021 and as the Senior Director, Medical Affairs Research from 2016 to 2018. Mary also worked at Intercept Pharmaceuticals as the Director, Clinical Research from 2015 to 2016.

Mary Erickson attended Penn State University from 1991 to 1997. No specific degree or field of study was mentioned.